Prof. Dr. Güzin Demirağ

Yayın Ağı

Makaleler 30

1. Obezitenin endometrioid tip endometrial adenokarsinomlu hastalarda prognoza etkisi

Gül Ö., Demirag G.

Journal of health sciences and medicine (Online) , cilt.8, sa.3, ss.383-388, 2025 (Hakemli Dergi)

2. Correlation of HALP Score and Menopause Status with Treatment Response in Hormone Receptor-Positive Breast Cancer Patients Receiving Neoadjuvant Chemotherapy

BAYRAKTAR D. I., TÜRKEL R., ALAN M., DEMİRAĞ G., TOMAK L., YOLA E.

Eurasian Journal of Medical Investigation , cilt.8, sa.2, ss.137-143, 2024 (Hakemli Dergi)

3. Evaluation of the relationship between Ki67 expression level and neoadjuvant treatment response and prognosis in breast cancer based on the Neo-Bioscore staging system

Süllü Y., Tomak L., Demirağ G., Kuru B., Ozen N., Karagoz F.

Discover Oncology , cilt.14, sa.1, 2023 (SCI-Expanded)

4. A case of castration-resistant metastatic prostate cancer who continued treatment with enzalutamide after epileptic seizure

Demir O., Demirağ G.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE , cilt.29, ss.498-501, 2023 (SCI-Expanded)

5. Prospective evaluation of hematological parameters in preoperative renal cell cancer patients

Demir O., Demirağ G., Aslan G.

BMC UROLOGY , cilt.22, sa.1, 2022 (SCI-Expanded)

6. Oscillometric evaluation of the effects of cardiotoxic chemotherapeutic agents on vascular stiffness

Kertmen O., Gülel O., Demirağ G., Özatlı D.

BLOOD PRESSURE MONITORING , cilt.27, sa.3, ss.199-207, 2022 (SCI-Expanded)

7. Prognostic significance of hemoglobin-to-red cell distribution width ratio in patients with metastatic renal cancer

Yilmaz H., Yilmaz A., Demirağ G.

FUTURE ONCOLOGY , cilt.17, sa.29, ss.3853-3864, 2021 (SCI-Expanded)

8. Predictive Significance of Ki-67 and Platelet Lymphocyte Ratio in Patients with Gastric Cancer Receiving Neoadjuvant FLOT Chemotherapy

Yilmaz H., Demirağ G., Süllü Y., Yilmaz A.

JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN , cilt.31, sa.5, ss.546-552, 2021 (SCI-Expanded)

9. Sigmoid Sinus Thrombosis Followed by Splenic Infarction Due to Imatinib Therapy in a Patient with Gastrointestinal Stromal Tumor; Hematological Side Effects of Imatinib

Yilmaz H., Demirağ G., Yilmaz A.

JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES , cilt.24, ss.148-152, 2021 (SCI-Expanded)

10. Quality of life study of patients with unresectable locally advanced or metastatic pancreatic adenocarcinoma treated with gemcitabine plus nab-paclitaxel versus gemcitabine alone: AX-PANC-SY001, a randomized phase-2 study

YALÇIN Ş., Dane F., Oksuzoglu B., Ozdemir N. Y., Isikdogan A., ÖZKAN M., et al.

BMC CANCER , cilt.20, sa.1, 2020 (SCI-Expanded)

11. Prognostic significance of pretreatment lymphopenia in colorectal cancer

Erdem D., Yucel I., BÜYÜKŞİMŞEK M., YILMAZ B., Demirağ G.

ANNALS OF CLINICAL AND ANALYTICAL MEDICINE , cilt.11, sa.2, ss.95-98, 2020 (ESCI)

12. Aggressive skin metastasis in lung cancer

Majidova N., Demirağ G., Pehlivanlar Kucuk M.

TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX , cilt.66, sa.3, ss.249-252, 2018 (ESCI)

13. Serum human epididymis protein 4 levels in colorectal cancer patients

Kemal Y., Demirağ G., Bedir A., Tomak L., Derebey M., Erdem D., et al.

MOLECULAR AND CLINICAL ONCOLOGY , cilt.7, sa.3, ss.481-485, 2017 (ESCI)

14. Early Response to Everolimus Therapy Detected on Ga-68-DOTATATE PET/CT in a Patient With Pancreatic Neuroendocrine Tumor

ÖZKAN E., SOYDAL Ç., UÇAK SEMİRGİN S., Yapıcı O., Atmaca A., Demirağ G.

CLINICAL NUCLEAR MEDICINE , cilt.41, sa.7, ss.561-563, 2016 (SCI-Expanded, Scopus)

15. Epithelial membrane protein 1 expression in ovarian serous tumors

Demirağ G., Kefeli M., Kemal Y., Yucel I.

ONCOLOGY LETTERS , cilt.11, sa.3, ss.2140-2144, 2016 (SCI-Expanded)

16. Virchow's node metastasis: an unusual presentation of ovarian cancer

Kemal Y., Kokcu A., Kefeli M., Tosun E., Demirağ G., Kurtoglu E., et al.

EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY , sa.3, ss.398-400, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

17. High body-mass index is not associated with worse clinicopathological characteristics in predominantly obese breast cancer patients

Kemal Y., Demirağ G., Teker F., Kut E., Kefeli M., Ekiz K., et al.

Experimental Oncology , cilt.37, sa.4, ss.281-284, 2015 (Scopus)

18. Primary testicular lymphoma: A single centre experience

Kemal Y., Teker F., Demirağ G., Yucel I.

Experimental Oncology , cilt.37, sa.3, ss.223-226, 2015 (Scopus)

19. Antithyroid peroxidase antibody positivity is associated with lower incidence of metastasis in breast cancer

Kemal Y., Demirağ G., Ekiz K., Yucel I.

MOLECULAR AND CLINICAL ONCOLOGY , cilt.3, sa.3, ss.629-632, 2015 (ESCI)

20. The value of red blood cell distribution width in endometrial cancer

Kemal Y., Demirağ G., Baş B., Önem S., Teker F., Yücel I.

Clinical Chemistry and Laboratory Medicine , cilt.53, sa.5, ss.823-827, 2015 (SCI-Expanded)

21. Quality of life in colorectal cancer patients during chemotherapy in the era of monoclonal antibody therapies

Teker F., Demirağ G., Erdem D., Kemal Y., Yucel I.

Journal of B.U.ON. , cilt.20, sa.2, ss.443-451, 2015 (SCI-Expanded)

22. Breast metastasis from squamous cell carcinoma of the cervix a case report

yasemin k., DEMİRAĞ G., KARAGÖZ F., BAYRAK İ. K., YÜCEL İ.

acto oncologica turcica , cilt.54, ss.38-43, 2015 (Scopus)

23. Elevated serum neutrophil to lymphocyte and platelet to lymphocyte ratios could be useful in lung cancer diagnosis

Kemal Y., Yucel I., Ekiz K., Demirağ G., YILMAZ B., Teker F., et al.

Asian Pacific Journal of Cancer Prevention , cilt.15, sa.6, ss.2651-2654, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma

24. Mean platelet volume could be a useful biomarker for monitoring epithelial ovarian cancer

Kemal Y., Demirağ G., Ekiz K., Yücel I.

Journal of Obstetrics and Gynaecology , cilt.34, sa.6, ss.515-518, 2014 (SCI-Expanded)

25. Single dose regorafenib-induced hypertensive crisis

YILMAZ B., Kemal Y., Teker F., Kut E., Demirağ G., Yucel I.

Experimental Oncology , cilt.36, sa.2, ss.134-135, 2014 (Scopus)

26. Expression of Plakophilins (PKP1, PKP2, and PKP3) in breast cancers

Demirağ G., Süllü Y., Yucel I.

MEDICAL ONCOLOGY , cilt.29, sa.3, ss.1518-1522, 2012 (SCI-Expanded)

27. THE ACCESS RATE TO DIAGNOSIS AND TREATMENT MODALITIES IN BREAST CANCER PATIENTS IN TURKEY; MULTICENTER OBSERVATIONAL STUDY

SAİP P. M., Keskin S., ÖZKAN M., Kaplan M. A., Aydogan F., Demirağ G., et al.

JOURNAL OF BREAST HEALTH , cilt.7, sa.2, ss.109-117, 2011 (ESCI) Sürdürülebilir Kalkınma

28. Matrix metalloproteinase-2 (MMP-2) and MMP-9 expression in invasive ductal carcinoma of the breast

Süllü Y., Demirağ G., Yildirim A., Karagöz F., Kandemir B.

PATHOLOGY RESEARCH AND PRACTICE , cilt.207, sa.12, ss.747-753, 2011 (SCI-Expanded)

29. Long-Time Survival in A Patient with Turcot Syndrome Diagnosed in The Fifth Decade: Case Report

Meydan D., Gürsel Ş. B., ÖZBEK OKUMUŞ N., Odabasi E., Yıldız L., Demirağ G.

JOURNAL OF NEUROLOGICAL SCIENCES-TURKISH , cilt.28, sa.1, ss.91-96, 2011 (SCI-Expanded) Sürdürülebilir Kalkınma

30. Expression of Plakophilins (PKP1, PKP2, and PKP3) in Gastric Cancers

Demirağ G., Süllü Y., Gurgenyatagi D., ÖZBEK OKUMUŞ N., Yucel I.

DIAGNOSTIC PATHOLOGY , cilt.6, 2011 (SCI-Expanded)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 29

1. Pembrolizumab vs placebo for early-stage non.small-cell lung cancer after resection and adjuvant therapy: Subgroup analysis of patients who received adjuvant chemotherapy in the phase 3 PEARLS/KEYNOTE-091 study

Oselin K., Shim B. Y., Okada M., Bryl M., Bonanno L., Demirag G., et al.

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 2 - 06 Haziran 2023, (Özet Bildiri)

2. A Case of Ovarian Cancer with Double Heterozygous Mutations in BRCA1 and BRCA2 genes

AKAR Ö. S., DEMİRAĞ G.

5. International Participated Erciyes Medical Genetics Days Congress, Nevşehir, Türkiye, 20 Şubat 2020, cilt.32, ss.70, (Özet Bildiri)

3. PANKREAS ADENOKANSERLERİNDE KEMOTERAPİ YANITINI DEĞERLENDİRMEDE İYOT TUTULUM MİKTARI KULLANILABİLİR Mİ? PROSPEKTİF DUAL ENERJİ BİLGİSAYARLI TOMOGRAFİ ÇALIŞMASI

ASLAN S., NURAL M. S., DEMİRAĞ G.

40.Uluslararası Katılımlı Radyoloji Kongresi, Türkiye, 5 - 11 Kasım 2019, (Tam Metin Bildiri)

4. Systemic immune-inflammation index and neutrophil to lymphocyte ratio for predicting tumor grade in neuroendocrine tumors.

YÜCEL İ., KEMAL Y., GÜN S., DEMİRAĞ G., DEREBEY M.

American Society of Clinical Oncology (ASCO) Annual Meeting 2018, CHICAGO, Amerika Birleşik Devletleri, 1 - 05 Haziran 2018, cilt.36, (Özet Bildiri)

Metrikler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

188

H-İndeks (WoS)

Atıf (Scopus)

438

H-İndeks (Scopus)

Atıf (Scholar)

H-İndeks (Scholar)

Proje

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler